杜瓦卢马布
放化疗
阶段（地层学）
医学
肺癌
肿瘤科
癌症
内科学
生物
免疫疗法
古生物学
无容量
作者
Ying Cheng,David R. Spigel,Byoung Chul Cho,К. К. Лактионов,Jian Fang,Yuanbin Chen,Yoshitaka Zenke,Ki Hyeong Lee,Qiming Wang,Alejandro Navarro,Reyes Bernabé,E.L. Buchmeier,John Wen-Cheng Chang,Yoshimasa Shiraishi,Sema Sezgin Göksu,A. Badzio,Anhui Shi,Davey B. Daniel,Nguyễn Thị Thái Hòa,Milada Zemanová
标识
DOI：10.1056/nejmoa2404873
摘要
Adjuvant therapy with durvalumab led to significantly longer overall survival and progression-free survival than placebo among patients with limited-stage small-cell lung cancer. (Funded by AstraZeneca; ADRIATIC ClinicalTrials.gov number, NCT03703297.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
BowieHuang
ceeray23
无极微光
Criminology34
niNe3YUE
子车茗
pluto
Zx_1993
djshao
Stella
不倦
李李李
黑猫乾杯
Dali
freyaaaaa
tuanheqi
积极从蕾
Dean
夜琉璃
小琳
蓝天
优美紫槐
ZOE
eric888
皖公网安备34019202002308
